Showing results (41-50 of 7,711) with videos related to
Sort By:
Pageof 772
Cancer Management and Research|October 17, 2019
Prospect of immunotherapy combined with anti-angiogenic agents in patients with advanced non-small cell lung cancerHongge Liang, Mengzhao WangZhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 4, 2010
[The role of TBNA in diagnosis and treatment of lung diseases]Xiao Zhao, Mengzhao WangThoracic Cancer|November 1, 2018
Afatinib as first-line treatment for advanced lung adenocarcinoma patients harboring HER2 mutation: A case report and review of the literatureYuequan Shi, Mengzhao WangFuture Oncology (London, England)|July 25, 2019
Circulating tumor cells in patients with lung cancer: developments and applications for precision medicineBing Tong, Mengzhao WangOncotargets and Therapy|April 11, 2020
MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met AxisHongge Liang, Mengzhao WangJournal of Thoracic Disease|September 4, 2018
Clinicopathological features of lung cancer in patients with rheumatoid arthritisXiaoyan Liu, Yan Xu, Qing Zhou, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|May 24, 2017
[Ocular Metastasis in Lung Cancer: a Retrospective Analysis in a Single Chinese Hospital and Literature Review]Yan Xu, Yiduo Sun, Jing Zhao, et al.Oncotarget|January 5, 2017
Total DNA input is a crucial determinant of the sensitivity of plasma cell-free DNA EGFR mutation detection using droplet digital PCRYu Zhang, Yan Xu, Wei Zhong, et al.Thoracic Cancer|September 29, 2024
Remarkable pathological response to neoadjuvant tepotinib in lung adenocarcinoma with MET exon 14 skipping mutation: A case reportRongzhen Li, Xiaoyan Liu, Yan Xu, et al.Thoracic Cancer|January 29, 2021
Prognostic impact of maximum standardized uptake value on 18 F-FDG PET/CT imaging of the primary lung lesion on survival in advanced non-small cell lung cancer: A retrospective studyXiaoling Qiu, Hongge Liang, Wei Zhong, et al.Pageof 772